-
2024-517759-11-00
6
Inflammatory Bowel Disease
-
2024-517796-21-00
5
Prevention of recurrence after a first episode of Venous Thromboemboli
-
2024-518835-13-00
5
Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar),
-
2025-521666-10-01
4
Mantle Cell Lymphoma
-
2025-522748-42-00
5
Ovarian cancer
-
2025-522981-61-00
4
2026-05-19
endometrial cancer
-
2024-511593-70-00
5
2026-04-27
Polyarticular-course juvenile idiopathic arthritis
-
2025-523234-66-00
4
2026-04-17
Well-Controlled Recurrent Pericarditis
-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2024-519901-36-00
5
2025-12-17
Patients with resected stage II-IIIA non-small cell lung cancer (NSCLC
-
2024-518973-32-00
5
2025-07-03
Chronic Graft-Versus-Host Disease
-
2024-516874-31-00
5
2024-12-10
Patients with a low-grade serous epithelial carcinoma of the ovary (LG
-
2023-507746-83-00
5
2024-11-27
Generalized Myasthenia Gravis
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2023-509180-24-00
4
2026-02-12
vulvar cancer
-
2024-519331-42-00
5
2025-08-22
pMMR endometrial carcinoma
-
2024-517432-21-00
4
2025-05-30
Gynecological Cancers
-
2024-516842-21-00
5
2025-01-09
Recurrent ovarian cancer
-
2024-516839-27-00
4
2024-12-09
BRCA wild-type advanced ovarian, fallopian tube and primitive peritone
-
2024-515914-41-00
4
2024-07-05
Chronic Lung Disease
-
2024-511959-18-01
5
2024-07-01
Acute Pulmonary Embolism
-
2022-502092-33-00
4
2024-05-31
Extensive-disease small cell lung cancer and high SLFN11-expression
-
2022-502775-29-01
5
2023-12-14
Early stage Follicular Lymphoma